Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Peritoneal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04753216
What this trial is testing

Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+6 more
Northwestern University 3
Testing effectiveness (Phase 2)Ended earlyNCT04826432
What this trial is testing

Pasireotide to Reduce Clinically Relevant Digestive Leakage After Complete Cytoreductive Surgery (CRS) Plus Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis

Who this might be right for
Peritoneal Carcinomatosis
Gustave Roussy, Cancer Campus, Grand Paris 6
Testing effectiveness (Phase 2)Study completedNCT01199263
What this trial is testing

Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
National Cancer Institute (NCI) 108
Testing effectiveness (Phase 2)Study completedNCT03759600
What this trial is testing

Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Takeda 20
Large-scale testing (Phase 3)Looking for participantsNCT05281471
What this trial is testing

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Who this might be right for
Platinum-resistant Ovarian CancerPlatinum-refractory Ovarian CancerFallopian Tube Cancer+4 more
Genelux Corporation 186
Large-scale testing (Phase 3)Study completedNCT04908787
What this trial is testing

A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd. 421
Not applicableStudy completedNCT02172690
What this trial is testing

Laparoscopic Staging for Locally Advanced Gastric Cancer in Chinese Patients

Who this might be right for
Gastric CancerPeritoneal Metastases
Peking University 452
Testing effectiveness (Phase 2)Study completedNCT01580410
What this trial is testing

Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix

Who this might be right for
Carcinoma of the AppendixPrimary Peritoneal Cavity Cancer
Wake Forest University Health Sciences 136
Testing effectiveness (Phase 2)UnknownNCT04846842
What this trial is testing

Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Lee's Pharmaceutical Limited 46
Not applicableUnknownNCT06091683
What this trial is testing

Adjuvant Pressurized Intraperitoneal Aerosol Chemotherapy to Prevent Colorectal Peritoneal Metastases (ProphyPIPAC)

Who this might be right for
Peritoneal Metastases From Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 10
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Testing effectiveness (Phase 2)Ended earlyNCT00091195
What this trial is testing

Depsipeptide (Romidepsin) in Treating Patients With Recurrent Ovarian Epithelial or Peritoneal Cavity Cancer

Who this might be right for
Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer
National Cancer Institute (NCI) 51
Early research (Phase 1)Study completedNCT00625092
What this trial is testing

Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies

Who this might be right for
Peritoneal Cavity Cancer
Masonic Cancer Center, University of Minnesota 17
Not applicableUnknownNCT03150992
What this trial is testing

EDMONd - Elemental Diet in Bowel Obstruction

Who this might be right for
Ovarian CancerOvarian NeoplasmsOvarian Disease+6 more
Royal Surrey County Hospital NHS Foundation Trust 34
Testing effectiveness (Phase 2)Ended earlyNCT01083537
What this trial is testing

Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction

Who this might be right for
Ovarian CancerPeritoneal CancerFallopian Tube Cancer+1 more
University Health Network, Toronto 1
Not applicableNot Yet RecruitingNCT07321730
What this trial is testing

Surgeons' Ability to Predict Pathological and Molecular Features of Peritoneal Carcinomatosis in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Testing effectiveness (Phase 2)Study completedNCT02040142
What this trial is testing

HIPEC for Peritoneal Carcinomatosis

Who this might be right for
Peritoneal CarcinomatosisColorectal CancerAppendiceal Cancer+3 more
Albert Einstein College of Medicine 51
Not applicableLooking for participantsNCT04570553
What this trial is testing

Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers

Who this might be right for
Endometrial Cancer
WellSpan Health 350
Testing effectiveness (Phase 2)Looking for participantsNCT06313801
What this trial is testing

Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions

Who this might be right for
Gastric Cancer
Nizhny Novgorod Regional Clinical Oncology Center 106
Not applicableStudy completedNCT04257045
What this trial is testing

Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives

Who this might be right for
Breast CarcinomaDeleterious CDH1 Gene MutationDeleterious DICER1 Gene Mutation+6 more
M.D. Anderson Cancer Center 46
Next Page